All News about Incyte CorpVia Talk Markets
Golden Cross Appears Before Incyte Investors
December 09, 2022
Via Benzinga
MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
September 29, 2022
Via Benzinga
Incyte’s Novel Mutant CALR Antibody Unveiled at ASH 2022 Plenary Scientific Session
December 11, 2022
From Incyte
Via Business Wire
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
November 01, 2022
From Incyte
Via Business Wire
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|